Drakenterprises
CardiologyDiabetesFamily MedicineEmergencyOrthopaedicsOtolaryngologyOncologyCross-cutting

Not clinical advice. Clinical Evidence is a current-awareness feed. It is not a clinical decision-support system, not medical advice, and not a substitute for clinical judgment, institutional protocols, or the original sources. Full text, NCCN recommendations, and Cochrane review bodies are not reproduced here.

Home · cross-cutting

NEJMArticle

Hypomethylating Agents plus Venetoclax as Compared with Intensive Chemotherapy in Patients with AML.

The New England journal of medicine · 09/03/2026

Authors: Schiffer, Charles A

Publication types: Editorial

PubMed abstract / permitted excerpt

New England Journal of Medicine, Volume 395, Issue 9, Page 917-919, September 3, 2026.

Full-text bodies are not stored. Official eTOC RSS plus PubMed abstracts. Full text remains on nejm.org (institutional access as applicable).

Clinical Evidence